Sabra Healthcare REIT, Inc.
SBRAReal Estate Reit Healthcare Facilities
Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024.
- Revenue
- +31.3%
- EPS
- +22.2%
- Free cash flow
- n/m
- Total debt
- −5.99%
Quarter to September 2026, against a year earlier
After hours trading: 20.39, unchanged, last trade 4:01pm Eastern.
Follow SBRA
Alert me
Where the cash went Q3 FY2026, quarter to Sep 30, 2026
Free cash flow was −$110.7M: capital expenditures were more than operating cash flow. Cash fell by $195.3M. Lines the picture does not name came to +$69.6M. What is a cash flow statement?
- Free cash flow
- −$110.7M −85.9% of operating cash flow
- Returned to shareholders
- $76.6M
- Debt, net
- −$191.5M repaid
- Change in cash
- −$195.3M over the period
| Operating cash flow | 129.0 |
|---|---|
| Capital expenditures | −239.7 |
| Free cash flow | −110.7 |
| Into investments, net | −1.9 |
| Dividends | −76.6 |
| Shares issued, net | +116.0 |
| Debt repaid, net | −191.5 |
| Other | +69.6 |
| Change in cash | −195.3 |
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Operating cash flow | $87M | $98M | $86M | $129M |
| Capex | −$80M | −$108M | −$210M | −$240M |
| Free cash flow | $7.4M | −$9.6M | −$124M | −$111M |
Figures in millions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Net Income |
28.56 | (25.25) | 40.81 | 27.15 |
+8 more quarters Free account |
Depreciation & Amortization |
64.78 | 56.38 | 53.13 | 51.41 | |
Non Cash Items (Other) |
20.34 | 67.87 | 3.84 | 13.14 | |
Accounts Receivable Change |
(4.53) | (10.39) | (1.53) | (2.32) | |
Change in payables and accrued liability |
19.82 | (2.80) | 2.11 | (1.94) | |
Operating Cash Flow |
128.97 | 85.82 | 98.36 | 87.43 | |
Capital expenditures |
(239.71) | (209.74) | (107.95) | (80.07) | |
Long-Term Investments Change (Net) |
(1.94) | (0.65) | (0.01) | 0.00 | |
Other investing activities |
69.81 | 296.89 | 2.88 | (36.47) | |
Investing cash flow |
(171.85) | 86.50 | (105.09) | (116.55) | |
Repayment/Issuance of Debt (Net) |
(191.54) | (37.53) | 137.27 | (65.53) | |
Equity Repurchase (Common, Net) |
115.99 | 55.95 | (8.25) | 39.43 | |
Dividends Paid (Total) |
(76.64) | (75.66) | (75.66) | (74.80) | |
Other financial activities |
(0.06) | (0.12) | (1.27) | 0.01 | |
Financing cash flow |
(152.25) | (57.36) | 52.10 | (100.89) | |
Exchange Rate Adjustment |
(0.13) | (0.07) | (0.06) | 0.64 | |
Change in Cash |
(195.26) | 114.89 | 45.31 | (129.38) | |
Beginning Cash |
0.00 | 0.00 | 78.14 | 0.00 | |
Ending Cash |
(195.26) | 114.89 | 123.45 | (129.38) | |
Stock Based Compensation |
3.92 | 4.09 | 3.10 | 3.07 | |
Dividends Paid (Common) |
(76.64) | (75.66) | (75.66) | (74.80) | |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | |
Assets Liabilities Change (Total) |
15.30 | (13.18) | 0.58 | (4.26) | |
Investments Change (Net) |
(1.94) | (0.65) | (0.01) | 0.00 | |
Issuance/Purchase of Shares |
115.99 | 55.95 | (8.25) | 39.43 |